Skip to main content

Advertisement

Log in

Inflammatory Cytokines Imbalance in the Very Early Phase of Acute Coronary Syndrome: Correlations with Angiographic Findings and In-Hospital Events

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The aim of this study is to investigate the release of some inflammatory cytokines (Cks) during the very early phase (first 24 h) of acute coronary syndrome (ACS). Twenty-six consecutive subjects admitted to coronary care unit with ACS underwent serial blood sampling in order to evaluate concentrations of interleukin (IL)-2, IL-10, IL-18, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ. Blood samples were taken within 6 h after onset of chest pain (T0), at 12 h (T1), and at 24 h (T2). Patients were thus divided into four groups comparing pro-inflammatory Ck release (IL-2, TNF-α, and IFN-γ) and anti-inflammatory activity (IL-10). Clinical features, risk factors, incidence of adverse events, and coronary angiography findings were compared with Ck activation. Ck levels were significantly increased if compared with baseline. Subjects with marked inflammatory response showed a higher incidence of left anterior descending coronary disease (IL-2, p < 0.001; TNF-α and IFN-γ, p < 0.05) and more often incurred early complications (IL-2, p < 0.05; IFN-γ, p < 0.001). A correlation was detectable between IL-18 levels and myocardial enzyme release (creatine kinase, r = 0.47; lactate dehydrogenase, r = 0.54; troponin I, r = 0.58; p < 0.05). TNF-α levels were associated with a worse prognosis at follow-up (Log rank, p < 0.05). A Ck activation characterizes the early phase of ACS. Early inflammatory reaction seems to correlate with coronary disease and adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brunetti, N.D., R. Troccoli, M. Correale, P.L. Pellegrino, and M. Di Biase. 2006. C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. International Journal of Cardiology 109: 248–256.

    Article  PubMed  Google Scholar 

  2. Brunetti, N.D., P.L. Pellegrino, M. Correale, R. Troccoli, and M. Di Biase. 2006. Early and late determinants of C-reactive protein release in patients with acute coronary syndrome. International Journal of Cardiology 112: 136–138.

    Article  PubMed  Google Scholar 

  3. Braunwald, E., E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin, C.J. Pepine, J.W. Schaeffer, E.E. Smith 3rd, D.E. Steward, P. Theroux, J.S. Alpert, K.A. Eagle, D.P. Faxon, V. Fuster, T.J. Gardner, G. Gregoratos, R.O. Russell, and S.C. Smith Jr. 2000. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the american college of cardiology/american heart association task force on practice guidelines (committee on the management of patients with unstable angina). Journal of the American College of Cardiology 36: 970–1062.

    Article  CAS  PubMed  Google Scholar 

  4. Lind, L. 2003. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169: 203–214.

    Article  CAS  PubMed  Google Scholar 

  5. Avanzas, P., R. Arroyo-Espliguero, J. Cosìn-Sales, J. Quiles, E. Zouridakis, and J.C. Kaski. 2004. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175: 151–157.

    Article  CAS  PubMed  Google Scholar 

  6. Vainas, T., F.R. Stassen, R. de Graaf, E.L. Twiss, S.B. Herngreen, R.J. Welten, L.H. van den Akker, M.P. van Dieijen-Visser, C.A. Bruggeman, and P.J. Kitslaar. 2005. C-reactive protein in peripheral arterial disease: Relation to severity of the disease and to future cardiovascular events. Journal of Vascular Surgery 42: 243–251.

    Article  PubMed  Google Scholar 

  7. Brevetti, G., A. Silvestro, S. Di Giacomo, R. Bucur, A.M. Di Donato, V. Schiano, and F. Scopacasa. 2003. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. Journal of Vascular Surgery 38: 374–379.

    Article  PubMed  Google Scholar 

  8. Haverkate, F., S.G. Thompson, S.D. Pyke, J.R. Gallimore, and M.B. Pepys. 1997. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 349: 462–466.

    Article  CAS  PubMed  Google Scholar 

  9. Lakoski, S.G., M. Cushman, W. Palmas, R. Blumenthal, R.B. D'Agostino, and D.M. Herrington. 2005. The relationship between blood pressure and C-reactive protein in the multi-ethnic study of atherosclerosis (MESA). Journal of the American College of Cardiology 46: 1869–1874.

    Article  CAS  PubMed  Google Scholar 

  10. Gu, L., Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, P. Libby, and B.J. Rollins. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein-deficient mice. Molecular Cell 2: 275–281.

    Article  CAS  PubMed  Google Scholar 

  11. Boring, L., J. Gosling, M. Cleary, and I.F. Charo. 1998. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894–897.

    Article  CAS  PubMed  Google Scholar 

  12. Mach, F., A. Sauty, A.S. Iarossi, G.K. Sukhova, K. Neote, P. Libby, and A.D. Luster. 1999. Differential expression of three T lymphocyte-activating CXC chemokines by humanatheroma-associated cells. Journal of Clinical Investigation 104: 1041–1050.

    Article  CAS  PubMed  Google Scholar 

  13. Topper, J.N., J. Cai, D. Falb, and M.A. Gimbrone Jr. 1996. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proceedings of the National Academy of Sciences of the United States of America 93: 10417–10422.

    Article  CAS  PubMed  Google Scholar 

  14. Qiao, J.H., J. Tripathi, N.K. Mishra, Y. Cai, S. Tripathi, X.P. Wang, S. Imes, M.C. Fishbein, S.K. Clinton, P. Libby, A.J. Lusis, and T.B. Rajavashisth. 1997. Role of Macrofage colony-stimulating factor in atherosclerosis: Studies of osteopetrotic mice. American Journal of Pathology 150: 1687–1699.

    CAS  PubMed  Google Scholar 

  15. Hillis, G.S., C.A. Terregino, P. Taggart, A.J. Killian, and A. Mangione. 2003. Inflammatory cytokines provide limited early prognostic information in emergency department patients with suspected myocardial ischemia. Annals of Emergency Medicine 42: 337–342.

    Article  PubMed  Google Scholar 

  16. Biasucci, L.M., A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A.G. Rebuzzi, G. Ciliberto, and A. Maseri. 1996. Elevated levels of IL-6 in unstable angina. Circulation 94: 874–887.

    CAS  PubMed  Google Scholar 

  17. Biasucci, L.M., G. Liuzzo, A. Fantuzzi, G. Caligiuri, A.G. Rebuzzi, F. Ginetti, C.A. Dinarello, and A. Maseri. 1999. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99: 2079–2084.

    CAS  PubMed  Google Scholar 

  18. Simon, A.D., S. Yazdani, W. Wang, A. Schwartz, and L.E. Rabbani. 2000. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. Journal of Thrombosis and Thrombolysis 9: 217–222.

    Article  CAS  PubMed  Google Scholar 

  19. Mizia-Stec, K., T. Mandecki, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, L. Szymanski, and T. Majewski. 2002. Selected cytokines and soluble forms of cytokine receptors in coronary artery disease. European Journal of Internal Medicine 13: 115–122.

    Article  CAS  PubMed  Google Scholar 

  20. Mazzone, A., S. De Servi, M. Vezzoli, G. Fossati, I. Mazzucchelli, D. Gritti, E. Ottini, A. Mussini, and G. Specchia. 1999. Plasma levls of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145: 369–374.

    Article  CAS  PubMed  Google Scholar 

  21. Yamashita, H., K. Shimada, E. Seki, H. Mokuno, and H. Daida. 2003. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. American Journal of Cardiology 91: 133–136.

    Article  CAS  PubMed  Google Scholar 

  22. Mallat, Z., P. Henry, S. Alouani, A. Scoazec, P. Beaufils, Y. Chvatchko, and A. Tedgui. 2002. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88: 467–469.

    Article  CAS  PubMed  Google Scholar 

  23. Seta, Y., T. Kanda, T. Tanaka, M. Arai, K. Sekiguchi, T. Yokoyama, M. Kurimoto, J. Tamura, and M. Kurabayashi. 2000. Interleukin-18 in acute myocardial infarction. Heart 84: 668.

    Article  CAS  PubMed  Google Scholar 

  24. Mallat, Z., A. Corbaz, A. Scoazec, S. Besnard, G. Leseche, Y. Chvatchko, and A. Tedgui. 2001. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104: 1598–1603.

    Article  CAS  PubMed  Google Scholar 

  25. Whitman, S.C., P. Ravisankar, and A. Daugherty. 2002. Interleukin-18 enhances atherosclerosis in apoliprotein R(-/-) mice through release of interferon-gamma. Circulation Research 90: E34–E38.

    Article  CAS  PubMed  Google Scholar 

  26. Mallat, Z., A. Corbaz, A. Scoazec, P. Graber, S. Alouani, B. Esposito, Y. Humbert, Y. Chvatchko, and A. Tedgui. 2001. Interleukin-18/interleukin-18 binding protein signalling modulates atherosclerotic lesion development and stability. Circulation Research 89: E41–E45.

    Article  CAS  PubMed  Google Scholar 

  27. Waehre, T., B. Halvorsen, J.K. Damas, A. Yndestad, F. Brosstad, L. Gullestad, J. Kjekshus, S.S. Froland, and P. Aukrust. 2002. Inflammatory imbalance between IL-10 and TNF-α in unstable angina potential plaque stabilizing effects of IL-10. European Journal of Clinical Investigation 32: 803–810.

    Article  CAS  PubMed  Google Scholar 

  28. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88–91.

    Article  CAS  PubMed  Google Scholar 

  29. Heeschen, C., S. Dimmeler, C.W. Hamm, S. Fichtlscherer, E. Boersma, M.L. Simoons, A.M. Zeiher, and for the CAPTURE Study Investigators. 2003. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107: 2109–2114.

    Article  CAS  PubMed  Google Scholar 

  30. Joint European Society of Cardiology/American College of Cardiology Committee. 2000. Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. European Heart Journal 21: 1502–1513.

    Article  Google Scholar 

  31. Anguera, I., F. Miranda-Guardiola, X. Bosch, X. Filella, M. Sitges, J.L. Marìn, A. Betriu, and G. Sanz. 2002. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. American Heart Journal 144: 811–817.

    PubMed  Google Scholar 

  32. Kuroda, T., N. Tanabe, M. Sakatsume, S. Nozawa, T. Mitsuka, H. Ishikawa, C.T. Tohyama, K. Nakazono, A. Murasawa, M. Nakano, and F. Gejyo. 2002. Interleukin-2 levels are elevated in the bone marrow serum of patients with mutilans-type rheumatoid arthritis. Clinical Rheumatology 21: 23–27.

    Article  CAS  PubMed  Google Scholar 

  33. Yoon, K.C., I.Y. Jeong, Y.G. Park, and S.Y. Yang. 2007. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26: 431–437.

    Article  PubMed  Google Scholar 

  34. Dall'era, M.C., P.M. Cardarelli, B.T. Preston, A. Witte, and J.C. Davis Jr. 2005. Type I interferon correlates with serological and clinical manifestations of SLE. Annals of the Rheumatic Diseases 64: 1692–1697.

    Article  PubMed  Google Scholar 

  35. Kucharz, E.J., and T. Wilk. 2000. Dynamics of serum interleukin-6 level in patients with acute myocardial infarction. European Journal of Internal Medicine 11: 253–256.

    Article  CAS  PubMed  Google Scholar 

  36. Deten, A., H.C. Volz, W. Briest, and H.G. Zimmer. 2002. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Research 55: 329–340.

    Article  CAS  PubMed  Google Scholar 

  37. Airaghi, L., M. Lettino, M.G. Manfredi, J.M. Lipton, and A. Catania. 1995. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. American Heart Journal 130: 204–211.

    Article  CAS  PubMed  Google Scholar 

  38. Pannitteri, G., B. Marino, P.P. Campa, R. Martucci, U. Testa, and C. Peschle. 1997. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. American Journal of Cardiology 80: 622–625.

    Article  CAS  PubMed  Google Scholar 

  39. Pudil, R., V. Pidrman, J. Krejsek, J. Gregor, M. Tichy, C. Andrys, and M. Drahosova. 1999. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clinica Chimica Acta 280: 127–134.

    Article  CAS  Google Scholar 

  40. Paroli, M., P. Mariani, D. Accapezzato, M. D'Alessandro, C. Di Russo, M. Bifolco, M.I. Sirinian, F. Fedele, G. Bruno, and G. Sardella. 2004. Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization. Clinical Immunology 112: 78–84.

    Article  CAS  PubMed  Google Scholar 

  41. Fichtlscherer, S., S. Breuer, C. Heeschen, S. Dimmeler, and A.M. Zeiher. 2004. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. Journal of the American College of Cardiology 44: 44–49.

    Article  CAS  PubMed  Google Scholar 

  42. Smith, D.A., S.D. Irving, J. Sheldon, D. Cole, and J.C. Kaski. 2001. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104: 746–749.

    Article  CAS  PubMed  Google Scholar 

  43. Gabriel, A.S., A. Martinsson, B. Wretlind, and S. Ahnve. 2004. IL-6 levels in acute and post myocardial infarction: Their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. European Journal of Internal Medicine 15: 523–528.

    Article  CAS  PubMed  Google Scholar 

  44. Nijm, J., A. Wikby, A. Tompa, A.G. Olsson, and L. Jonasson. 2005. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. American Journal of Cardiology 95: 452–456.

    Article  CAS  PubMed  Google Scholar 

  45. Tziakas, D.N., G.K. Chalikias, H.I. Hatzinikolaou, J.T. Parissis, E.D. Papadopoulos, G.A. Trypsianis, E. Papadopoulou, I.K. Tentes, S.M. Karas, and D.I. Hatseras. 2003. Anti-inflammatory cytokine profile in acute coronary syndromes: Behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. International Journal of Cardiology 92: 169–175.

    Article  PubMed  Google Scholar 

  46. Hojo, Y., U. Ikeda, M. Takahashi, and K. Shimada. 2002. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 161: 403–408.

    Article  CAS  PubMed  Google Scholar 

  47. Woldbaek, P.R., T. Tønnessen, U.L. Henriksen, G. Florholmen, P.K. Lunde, T. Lyberg, and G. Christensen. 2003. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovascular Research 59: 122–131.

    Article  CAS  PubMed  Google Scholar 

  48. Patti, G., A. D'Ambrosio, A. Dobrina, G. Dicuonzo, C. Giansante, N. Fiotti, A. Abbate, G. Guarnieri, and G. Di Sciascio. 2002. Interleukin-1 receptor antagonist: A sensitive marker of instability in patients with coronary artery disease. Journal of Thrombosis and Thrombolysis 14: 139–143.

    Article  PubMed  Google Scholar 

  49. Marx, N., Fj Neumann, I. Ott, M. Gawaz, W. Koch, T. Pinkau, and A. Schömig. 1997. Induction of cytokine expression in leukocytes in acute myocardial infarction. Journal of the American College of Cardiology 30: 165–170.

    Article  CAS  PubMed  Google Scholar 

  50. Brunetti, N.D., I. Munno, P.L. Pellegrino, V. Ruggiero, M. Correale, A. Cuculo, L. De Gennaro, G. Campanale, G. Mavilio, L. Ziccardi, and M. Di Biase. 2007. Inflammatory cytokine imbalance after coronary angioplasty: Links with coronary atherosclerosis. Journal of Interventional Cardiology 20: 248–257.

    Article  PubMed  Google Scholar 

  51. Keso, T., M. Perola, P. Laippala, E. Ilveskoski, T.A. Kunnas, J. Mikkelsson, A. Penttilä, M. Hurme, and P.J. Karhunen. 2001. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 154: 691–697.

    Article  CAS  PubMed  Google Scholar 

  52. DePalma, R.G., V.W. Hayes, H. Treat Cafferata, H.A. Mohammadpour, B.K. Chow, L.R. Zacharski, and M.R. Hall. 2003. Cytokine signatures in atherosclerotic claudicants. Journal of Surgical Research 111: 215–221.

    Article  CAS  PubMed  Google Scholar 

  53. Bennermo, M., C. Held, F. Green, L.E. Strandberg, C.G. Ericsson, L.O. Hansson, H. Watkins, A. Hamsten, and P. Tornvall. 2004. Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174: 157–163.

    Article  CAS  PubMed  Google Scholar 

  54. Théroux, P., P.W. Armstrong, K.W. Mahaffey, J.S. Hochman, K.J. Malloy, S. Rollins, J.C. Nicolau, J. Lavoie, T.M. Luong, J. Burchenal, and C.B. Granger. 2005. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: A substudy of the COMMA trial. European Heart Journal 26: 1964–1970.

    Article  PubMed  Google Scholar 

  55. Hochman, J.S. 2003. Cardiogenic shock complicating acute myocardial infarction: Expanding the paradigm. Circulation 107: 2998–3002.

    Article  PubMed  Google Scholar 

  56. Brunetti, N.D., P.L. Pellegrino, M. Correale, L. De Gennaro, A. Cuculo, and M. Di Biase. 2008. Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction. Journal of Thrombosis and Thrombolysis 26: 196–202.

    Article  CAS  PubMed  Google Scholar 

  57. Raymond, R.J., G.J. Dehmer, T.C. Theoharides, and E.N. Deliargyris. 2001. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. American Heart Journal 141: 435–438.

    Article  CAS  PubMed  Google Scholar 

  58. Valgimigli, M., C. Ceconi, P. Malagutti, E. Merli, O. Soukhomovskaia, G. Francolini, G. Cicchitelli, A. Olivares, G. Parrinello, G. Percoco, G. Guardigli, D. Mele, R. Pirani, and R. Ferrari. 2005. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation 111: 863–870.

    Article  CAS  PubMed  Google Scholar 

  59. Cain, B.S., D.R. Meldrum, C.A. Dinarello, X. Meng, K.S. Joo, A. Banerjee, and A.H. Harken. 1999. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Critical Care Medicine 27: 1309–1318.

    Article  CAS  PubMed  Google Scholar 

  60. Gurevitch, J., I. Frolkis, Y. Yuhas, B. Lifschitz-Mercer, E. Berger, Y. Paz, M. Matsa, A. Kramer, and R. Mohr. 1997. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. Journal of the American College of Cardiology 30: 1554–1561.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

All authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Natale Daniele Brunetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brunetti, N.D., Munno, I., Pellegrino, P.L. et al. Inflammatory Cytokines Imbalance in the Very Early Phase of Acute Coronary Syndrome: Correlations with Angiographic Findings and In-Hospital Events. Inflammation 34, 58–66 (2011). https://doi.org/10.1007/s10753-010-9208-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-010-9208-1

KEY WORDS

Navigation